TY - JOUR T1 - Evaluation of the Modified HASBLED Score for Prediction of In-hospital Mortality in Patients with COVID-19 TT - Evaluation of the Modified HASBLED Score for Prediction of In-hospital Mortality in Patients with COVID-19 AU - Aslan, Burhan AU - İnci, Ümit AU - Işık, Ferhat AU - Karahan, Mehmet Zülküf AU - Çap, Murat AU - Tatlı, İsmail AU - Boyraz, Bedrettin AU - Okşul, Metin PY - 2021 DA - December DO - 10.5798/dicletip.1037627 JF - Dicle Medical Journal JO - diclemedj PB - Dicle University WT - DergiPark SN - 1300-2945 SP - 746 EP - 753 VL - 48 IS - 4 LA - en AB - Objective: The COVID-19 outbreak continues to be the common cause of deaths worldwide in recent times. Preventing poor outcomes (death, intubation, non-invasive ventilation, need for intensive care) is the first goal for hospitalized patients. Identifying high-risk patients during hospitalization can provide more effective follow-up and treatment. The HASBLED score is highly predictive for bleeding events in atrial fibrillation patients. We used the HASBLED score to identify patients with frailty, vulnerability, and comorbid diseases, not as a bleeding score. So, we used albumin level instead of labile INR in the score because it shows both the nutritional status and inflammation. We aim to evaluate the modified HASBLED score for predicting mortality and poor outcomes in hospitalized COVID-19 patients.Method: In total, 2850 hospitalized COVID-19 patients were screened retrospectively and, after the exclusions, 2041 patients were included in the study. The patients were divided into two groups according to the M-HASBLED score as KW - HASBLED score KW - mortality KW - COVID-19 KW - hospitalization CR - 1.World Health Organization (WHO). Coronavirusdisease (COVID-19) outbreak, https://www.who.int/westernpacific/emergencies/covid-19 CR - 2.F. Zhou, T. Yu, R. Du, et al. Clinical course and riskfactors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyLancet, 395 (10229) 2020: 1054-62. CR - 3.Chen R, Liang W, Jiang M, et al. Medical TreatmentExpert Group for COVID-19. Risk factors of fataloutcome in hospitalized subjects with coronavirusdisease 2019 from a nationwide analysis in China.Chest 2020. UR - https://doi.org/10.5798/dicletip.1037627 L1 - https://dergipark.org.tr/en/download/article-file/2136300 ER -